TR201716062A2 - MANUFACTURING METHOD OF AN EXOSOMAL THERAPEUTIC CARRIER AND AN EXOSOMAL THERAPEUTIC CARRIER OBTAINED SUITABLE FOR THIS METHOD - Google Patents

MANUFACTURING METHOD OF AN EXOSOMAL THERAPEUTIC CARRIER AND AN EXOSOMAL THERAPEUTIC CARRIER OBTAINED SUITABLE FOR THIS METHOD Download PDF

Info

Publication number
TR201716062A2
TR201716062A2 TR2017/16062A TR201716062A TR201716062A2 TR 201716062 A2 TR201716062 A2 TR 201716062A2 TR 2017/16062 A TR2017/16062 A TR 2017/16062A TR 201716062 A TR201716062 A TR 201716062A TR 201716062 A2 TR201716062 A2 TR 201716062A2
Authority
TR
Turkey
Prior art keywords
exosomal
therapeutic carrier
manufacturing
therapeutic
obtained suitable
Prior art date
Application number
TR2017/16062A
Other languages
Turkish (tr)
Inventor
Teki̇n Şaban
Erçelen Ceylan Şebnem
Original Assignee
Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak filed Critical Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak
Priority to TR2017/16062A priority Critical patent/TR201716062A2/en
Priority to PCT/IB2018/058077 priority patent/WO2019077534A1/en
Publication of TR201716062A2 publication Critical patent/TR201716062A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu buluş, kişiye özgü, hedeflendirilmiş ve düşük toksisiteye sahip olan eksozomal terapötik taşıyıcısı üretim yöntemi ve bu yönteme uygun olarak üretilen bir eksozomal terapötik taşıyıcı ile ilgilidir.The present invention relates to an individual, targeted, and low toxicity exosomal therapeutic carrier production method and an exosomal therapeutic carrier produced according to this method.

TR2017/16062A 2017-10-18 2017-10-18 MANUFACTURING METHOD OF AN EXOSOMAL THERAPEUTIC CARRIER AND AN EXOSOMAL THERAPEUTIC CARRIER OBTAINED SUITABLE FOR THIS METHOD TR201716062A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/16062A TR201716062A2 (en) 2017-10-18 2017-10-18 MANUFACTURING METHOD OF AN EXOSOMAL THERAPEUTIC CARRIER AND AN EXOSOMAL THERAPEUTIC CARRIER OBTAINED SUITABLE FOR THIS METHOD
PCT/IB2018/058077 WO2019077534A1 (en) 2017-10-18 2018-10-18 An exosomal therapeutic carrier production method and an exosomal therapeutic carrier properly obtained with this method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/16062A TR201716062A2 (en) 2017-10-18 2017-10-18 MANUFACTURING METHOD OF AN EXOSOMAL THERAPEUTIC CARRIER AND AN EXOSOMAL THERAPEUTIC CARRIER OBTAINED SUITABLE FOR THIS METHOD

Publications (1)

Publication Number Publication Date
TR201716062A2 true TR201716062A2 (en) 2019-05-21

Family

ID=64607039

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/16062A TR201716062A2 (en) 2017-10-18 2017-10-18 MANUFACTURING METHOD OF AN EXOSOMAL THERAPEUTIC CARRIER AND AN EXOSOMAL THERAPEUTIC CARRIER OBTAINED SUITABLE FOR THIS METHOD

Country Status (2)

Country Link
TR (1) TR201716062A2 (en)
WO (1) WO2019077534A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900007785A1 (en) * 2019-05-31 2020-12-01 Univ Degli Studi Milano Extracellular vesicles to deliver therapeutic or diagnostic drugs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788780B1 (en) * 1999-01-27 2001-03-30 Ap Cells Inc PROCESS FOR THE PREPARATION OF MEMBRANE VESICLES
EP1523318A4 (en) 2002-06-24 2007-07-04 Res Dev Foundation Treatment of human multiple myeloma by curcumin
US20120315324A1 (en) 2010-02-05 2012-12-13 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
CN102349998A (en) 2011-10-20 2012-02-15 天津大学 Hydrophobic anticancer medicinal preparation on basis of exosome
US20130273544A1 (en) * 2012-04-17 2013-10-17 Life Technologies Corporation Methods and compositions for exosome isolation
WO2014134132A1 (en) * 2013-02-26 2014-09-04 University Of Louisville Research Foundation, Inc. Milk-derived microvesicle compositions and related methods
JP2017526388A (en) * 2014-09-05 2017-09-14 エクサーカイン コーポレイションＥｘｅｒｋｉｎｅ Ｃｏｒｐｏｒａｔｉｏｎ Isolation of exosomes
JP2018520125A (en) * 2015-06-10 2018-07-26 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム Use of exosomes for treatment of disease
WO2017054086A1 (en) * 2015-10-01 2017-04-06 Exerkine Corporation Treatment of genetic myopathies using bioengineered exosomes

Also Published As

Publication number Publication date
WO2019077534A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
CL2020000594S1 (en) Headphone case.
CY1122454T1 (en) PALBOCICLIB SOLID DOSAGE FORMS
BR112016028045A2 (en) MODIFIED BIOPOLYMERS, AND THEIR PRODUCTION METHODS
EA201792205A1 (en) HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
EA202092987A2 (en) LIPID CONTAINING DOCOSAPENTAENIC ACID
UY34844A (en) SOLID FORMS OF AN ANTIVIRAL COMPOUND
ZA201902141B (en) Acid-alpha glucosidase variants and uses thereof
CL2020000946A1 (en) Methods and compositions for the production of nucleoside triphosphate and ribonucleic acid
CY1123920T1 (en) ANTI-INFLUENT POLYCYCLIC PYRIDONE DERIVATIVE AND ITS PRODRUG
BR112018010360A2 (en) anti-c1q complement factor fab fragments and uses thereof
PH12019500376A1 (en) Acid-alpha glucosidase variants and uses thereof
EA202090720A1 (en) GalNAc DERIVATIVES
EA201792021A1 (en) JAK INHIBITOR
EA201591931A1 (en) COMPOSITIONS OF OXABICYCLOPTANES AND OXABITICLOCEPTENS
TR201904599T4 (en) Use of isomeric pure or highly isomeric enriched cis- or trans- (2-isobutyl-4-methyl-tetrahydropyran-4-yl) acetate.
CY1120759T1 (en) PREPARATION OF DIGLYCOSITE (S, S) -SECOCOSOLARICIRESINOL AND DIGLYCOSITE (R, R) -SECOSOSOLARICIRESINOL
EA201792612A1 (en) 6-AMINOHINOLIN-3-CARBONITRILES AS COT MODULATORS
UY36737A (en) 3-AMINO-1,5,6,7-TETRAHIDRO-4H-INDOL-4-ONAS
UY36500A (en) COMPOSITIONS OF THE NITRIFICATION INHIBITOR AND METHODS OF PREPARATION OF THE SAME
BR112018011633A2 (en) pad4 aza-benzimidazole inhibitors
EA201600026A1 (en) BACTERIAL HYALURONIDASE AND METHOD FOR ITS PRODUCTION
EA201792372A1 (en) COMPOSITIONS AND METHODS FOR ACTIVE OBSERVATION FOR PROSTATE CANCER
CU24428B1 (en) QUINOLIZINONE DERIVATIVES AS PI3K INHIBITORS
TR201904143T4 (en) Silylated polyurethanes.
TR201716062A2 (en) MANUFACTURING METHOD OF AN EXOSOMAL THERAPEUTIC CARRIER AND AN EXOSOMAL THERAPEUTIC CARRIER OBTAINED SUITABLE FOR THIS METHOD